HBM Holdings (02142.HK): Included as a Constituent Stock of Hang Seng Composite Index
NewTimeSpace News: On August 24, 2026,HBM Holdings(02142.HK) announced that the Company has been selected by Hang Seng Indexes Company Limited to be a constituent stock of the Hang Seng Composite Index, effective September 7, 2026.
HBM Holdingsstated that upon inclusion, the Company’s shares are expected to meet the eligibility criteria for trading under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programmes. This will help expand the shareholder base, boost share trading liquidity, and continuously enhance the Company’s investment value and reputation in the capital market.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HBM Holdings(02142.HK): Strategic Cooperation Established with Sinopharm Group
- HBM Holdings(02142.HK): IND Application of HBM7575 for Asthma Treatment Approved by NMPA
- HBM HOLDINGS-B (02142.HK): IND application of HBM7004 for advanced solid tumors approved by NMPA
- HBM HOLDINGS-B (02142.HK): Expected Profit of USD62 Million–USD67 Million for H1 2026; Revenue Stood at Approximately USD101 Million in Corresponding Period Last Year